We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$91.6M
Cap. Flow %
6.65%
Top 10 Hldgs %
28.56%
Holding
1,934
New
622
Increased
464
Reduced
326
Closed
465

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Communication Services 8.62%
3 Healthcare 8.45%
4 Financials 8.14%
5 Consumer Discretionary 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVHI
1401
DELISTED
A V Homes, Inc.
AVHI
$6K ﹤0.01%
+300
New +$5.29K
ADUS icon
1402
Addus HomeCare
ADUS
$2.23B
$5K ﹤0.01%
100
-964
-91% -$37K
AGEN
1403
Agenus
AGEN
$290M
$5K ﹤0.01%
57
-28
-33% -$2.49K
BKN
1404
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
$5K ﹤0.01%
+347
New +$4.87K
HCKT icon
1405
Hackett Group
HCKT
$287M
$5K ﹤0.01%
+300
New +$5.01K
MRIN
1406
DELISTED
Marin Software
MRIN
$5K ﹤0.01%
+133
New +$6.99K
SF
1407
Stifel
SF
$12.6B
$5K ﹤0.01%
+187
New +$5.3K
CORR.PRA
1408
DELISTED
CorEnergy Infrastructure Trust, Inc Depositary Shares representing a 1/100th fractional interest of a share of 7.375% Series A Cumulative Redeemable Preferred Stock
CORR.PRA
$5K ﹤0.01%
194
MTEM
1409
DELISTED
Molecular Templates, Inc.
MTEM
$5K ﹤0.01%
+40
New +$6.02K
RAVN
1410
DELISTED
Raven Industries Inc
RAVN
$5K ﹤0.01%
131
-6,302
-98% -$225K
INSY
1411
DELISTED
Insys Therapeutics, Inc.
INSY
$5K ﹤0.01%
840
+204
+32% +$1.68K
LOXO
1412
DELISTED
Loxo Oncology, Inc
LOXO
$5K ﹤0.01%
44
-317
-88% -$33.7K
FORR icon
1413
Forrester Research
FORR
$224M
$4K ﹤0.01%
+100
New +$4.27K
IFRX icon
1414
InflaRx
IFRX
$271M
$4K ﹤0.01%
+155
New +$4.09K
SGMO
1415
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4K ﹤0.01%
218
-370
-63% -$7.91K
TPB icon
1416
Turning Point Brands
TPB
$1.74B
$4K ﹤0.01%
+200
New +$4.22K
ANW
1417
DELISTED
Aegean Marine Petroleum Network
ANW
$4K ﹤0.01%
+1,958
New +$7.12K
ATI icon
1418
ATI
ATI
$31B
$3K ﹤0.01%
+113
New +$3.03K
AUB icon
1419
Atlantic Union Bankshares
AUB
$5.97B
$3K ﹤0.01%
+80
New +$3.02K
DWSN icon
1420
Dawson Geophysical
DWSN
$135M
$3K ﹤0.01%
+525
New +$3.08K
EHI
1421
Western Asset Global High Income Fund
EHI
$178M
$3K ﹤0.01%
300
FNLC icon
1422
First Bancorp
FNLC
$399M
$3K ﹤0.01%
+120
New +$3.37K
GRC icon
1423
Gorman-Rupp
GRC
$2.21B
$3K ﹤0.01%
119
-481
-80% -$14.1K
HYMB icon
1424
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.19B
$3K ﹤0.01%
90
KALV
1425
DELISTED
KalVista Pharmaceuticals
KALV
$3K ﹤0.01%
+300
New +$3.14K

Similar funds

Prelude Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Prelude Capital Management held 1,934 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Prelude Capital Management deployed $91.6M of net new capital in Q1 2018, opening 622 new positions and adding to 464 existing holdings. Its largest new stake was XL Group Ltd.: 571,194 shares worth $31.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Twenty-First Century Fox, Inc. Class B, an estimated $10.5M trimmed.

  • Prelude Capital Management's largest Q1 2018 buy was XL Group Ltd.: 571,194 shares worth $31.6M.
  • Prelude Capital Management added most to NXP Semiconductors in Q1 2018, an estimated $19.7M increase.
  • Prelude Capital Management's biggest Q1 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $10.5M.
  • Prelude Capital Management fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $21.7M.
  • Prelude Capital Management's ten largest holdings make up 29% of its $1.38B portfolio in Q1 2018.
  • Prelude Capital Management opened 622 new positions and closed 465 in Q1 2018.
  • Prelude Capital Management's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Prelude Capital Management's 13F filing for Q1 2018, filed 15 May 2018.